Sandoz Breaks $10bn Barrier With Biosimilars Boost

Company Passes Sales Milestone In 2024 After 29% Rise In Biosimilars Turnover

 
• By Dave Wallace
  
Sandoz has achieved more than $10bn in annual sales (Shutterstock)

More from Earnings

More from Generics